Organization
Venatorx Pharmaceuticals
4 clinical trials
Clinical trial
A Phase 3, Randomized, Double-blind, Active Controlled Noninferiority Study Evaluating the Efficacy, Safety, and Tolerability of Cefepime/VNRX-5133 in Adults With Complicated Urinary Tract Infections (cUTI), Including Acute PyelonephritisStatus: Completed, Estimated PCD: 2021-12-14
Clinical trial
VNRX-7145-103: A Phase 1, Open-label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal FunctionStatus: Completed, Estimated PCD: 2023-11-21
Clinical trial
VNRX-7145-104: an Open-label, Cross-over Study to Evaluate the Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Ceftibuten/VNRX-7145 in Healthy Participants.Status: Completed, Estimated PCD: 2023-02-06
Clinical trial
A Phase 3 Study to Evaluate Cefepime-taniborbactam Compared to Meropenem in Adults With Ventilator Associated Bacterial Pneumonia (VABP) or Ventilated Hospital Acquired Bacterial Pneumonia (vHABP)Status: Not yet recruiting, Estimated PCD: 2027-03-01